The latest from OTC Perspectives
WPP's Sorrell: Slow Growth in 2010 for Ad Industry
Friday, 11 December 2009, 01:58 PM
Sir Martin Sorrell, chief executive of the advertising group WPP, predicted a slow growth in the upcoming year for the advertising industry during his presentation at the annual UBS Global Media & Communications Conference earlier this week. According to MediaPost, Sorrell acknowledged that the industry saw an improvement in November and that it is losing less ground than it has been. However, he remains uncertain as to how sustainable that growth will be.
Sorrell also said that there is a lot of potential in mobile advertising, thinking that it will grow largely due to smartphones, such as Apple's iPhone, and Google's Android operating system, as stated by a story from the economics Web site, www.paidcontent.org. He anticipates that social networking Web sites, such as Facebook and Twitter, will be short-lived fads. He stated that Google is "the push for this" because, at the moment, they are very strong, "focused and therefore, more effective."
According to a Wall Street Journal report, WPP's GroupM "expects global advertising revenue to return to annual growth in the range of 6% to 7% from 2011 to 2014." GroupM is projecting a 0.8% growth in 2010, higher than its earlier anticipated 1.4% decline. Sorrell also told attendees at the recent Reuters Global Media Summit that he does not believe that the industry is at the end of the recession, nor is it recovering quite yet.
Related articles
Perrigo Responds to Gluten-Free Trend
The Perrigo Company, a global OTC and generic pharmaceutical company, will launch a labeling program to help consumers identify gluten-free pharmaceutical products
GSK Lights Up New Nicorette Campaign
GSK launched a new $15 million campaign for its OTC nicotine gum Nicorette during primetime TV on December 7th. The campaign, which features the tagline "Quitting
Merck OTC Heartburn Treatment Receives FDA Approval
San Diego-based pharmaceutical company Santarus received regulatory approval Dec. 1 for its OTC heartburn drug Zegerid. The OTC drug, licensed to Schering-Plough Health
Novartis to Launch OTC Prevaid with $200 Million Campaign
Novartis Consumer Health is backing the launch of OTC heartburn medication Prevacid with a $200 million ad campaign, MM&M reports.
WebMD Founder, Dr. Oz to Launch Web 3.0 Healthcare Platform
Jeff Arnold, founder of WebMD, has partnered with health expert and TV host Dr. Mehmet Oz to launch Sharecare Inc., a Web 3.0 platform organizing and answering
| ABOUT SSL CERTIFICATES |
